Merck KGaA Enters Partnership With China's Hengrui for Up to $1.5 Bln
By Adria Calatayud Germany's Merck KGaA has entered into a partnership to license a cancer drug developed by China's Jiangsu Hengrui Pharmaceuticals for up...
Source: marketwatch.com